3,500+ Healthcare Practices Get Gaps-in-Care Alerts via Veradigm Payer Insights Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that more than 3,500 healthcare practices…
LifeStance Names Dave Bourdon CEO, Ken Burdick Executive Chairman LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental health care,…
Eric Peacock Appointed Chief Patient Officer of Swoop Swoop, a leader in AI-powered, data-driven, and privacy-compliant omnichannel healthcare marketing, has announced the appointment of Eric Peacock as Chief Patient Officer.…
Incyte Presents Phase 3 Results of Ruxolitinib Cream for Prurigo Nodularis at AAD 2025 Incyte (Nasdaq: INCY) today announced the results of its pivotal Phase 3 TRuE-PN clinical trial program,…
AAD 2025: Almirall Presents Early-Stage Pipeline and Real-World Evidence on Tirbanibulin for AK Almirall, S.A. (ALM), a global pharmaceutical company focused on medical dermatology, showcased five scientific posters at the…
PureHealth Partners with Abu Dhabi Early Childhood Authority for Child Healthcare Solutions PureHealth has announced a strategic partnership with the Abu Dhabi Early Childhood Authority (ECA) to improve health outcomes…
Andlauer Healthcare Group Announces Nova Pack-NowPac Joint Venture Andlauer Healthcare Group Inc. (TSX: AND) (“AHG” or the “Company”) announced today the launch of a new joint venture that will combine…
iMH Launches First Private Mental Health Hospital in Queensland Queensland’s first private mental health hospital, Nundah Private Hospital, has officially opened, addressing significant gaps in Australia’s mental health system. Operated…
Peach State Health Plan and Centene Foundation Invest in Atlanta Housing Development Peach State Health Plan, a care management organization serving residents across Georgia, and the Centene Foundation, the philanthropic…
Protagonist and Takeda Report Positive Phase 3 VERIFY Study Results of Rusfertide for Polycythemia Vera Protagonist Therapeutics, Inc. and Takeda have announced positive topline results from their Phase 3 VERIFY…
Astria Therapeutics Launches Phase 3 ALPHA-ORBIT Trial of Navenibart for Hereditary Angioedema Astria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company dedicated to developing transformative therapies for allergic and immune diseases,…
Adagio Medical Announces Restructuring to Accelerate US IDE Trial and Innovation Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a leader in catheter ablation technologies for treating cardiac arrhythmias, today announced a…